Introduction
Quantum physics intersects with medicine across a spectrum that ranges from widely deployed clinical technologies to emerging computational and sensing paradigms and, separately, more speculative proposals about mind and consciousness. The applied intersection is visible in diagnostic and imaging technologies, where horizon scanning across health care identified 116 “quantum technologies,” with magnetoencephalography (MEG), quantum dots, and SQUID-based devices frequently used for brain mapping, imaging, and cardiac diagnostics, and with diagnostics representing 54% of identified uses in that scan[1]. The same horizon scan reports that quantum computing (28%) and quantum dots (24%) were the most common application categories and that 27% of these technologies incorporate AI, especially for personalized medicine and imaging diagnosis[1].
A second line of intersection is mechanistic: several reviews argue that “processes essential to life” (e.g., electron tunnelling in respiratory complexes, proton-coupled transfer in metabolic enzymes, coherence in photosynthesis, and spin dynamics in radical signalling) are “inherently quantum mechanical” and thus potentially link electronic-scale physics to clinical phenotypes[2]. A third line is conceptual and theoretical, where some authors explicitly tie consciousness and definite perception to the quantum measurement problem and to quantum-state reduction as a proposed mechanism for decision and perception[3].
Foundational common aspects
A shared foundation across quantum physics and medicine is that clinically valuable signals and interventions often originate at molecular, atomic, or subatomic scales, even when the clinical phenomena are macroscopic, and multiple reviews explicitly connect “nanoscale particles” and “subatomic” quantum principles to biomedical devices and biomedical hypotheses[4, 5]. Several healthcare-oriented reviews emphasize that quantum computing differs from classical computing by using qubits and quantum phenomena (superposition and entanglement) to represent information in ways that are fundamentally different from classical bits, and they treat this as the enabling basis for downstream biomedical applications such as molecular simulation and diagnostics[6].
Measurement and coherence are also cross-cutting themes, because both diagnostics and quantum devices require careful management of how observation affects signals. One review notes that measuring a quantum system “inevitably disturbs it,” and uses this to motivate quantum key distribution as a security primitive that can detect eavesdropping through detectable anomalies introduced by measurement[7]. In sensing and diagnostics, another review frames coherence time as a direct determinant of sensitivity and highlights that NV centers in diamond can maintain coherence at room temperature, enabling detection of weak magnetic fields relevant to neuronal or biomolecular signals[8].
Finally, many authors treat decoherence and “warm, wet and noisy” biological environments as a central bridge problem that must be solved to connect quantum models to living systems, while also arguing that evidence for quantum explanations across biological functions has motivated quantum biology as a distinct field of study[4].
Applied and technological intersections
The strongest and most immediate common ground between quantum physics and medicine lies in technologies that either directly exploit quantum phenomena (e.g., spin physics in MRI, photon statistics in quantum imaging) or use quantum computation/sensing to improve healthcare workflows. The literature also suggests that these technologies cluster around diagnostic support, personalization, and computational acceleration, consistent with horizon-scanning results showing that diagnostics dominate identified quantum-healthcare technologies and that quantum computing and quantum dots are especially common application types[1].
Medical imaging
Medical imaging is described as a cornerstone of clinical diagnosis and treatment planning, and multiple reviews explicitly describe how quantum phenomena are being harnessed to improve imaging speed, resolution, and signal quality[9]. One imaging-focused review notes that “spin-based quantum principles underlie the operation of MRI,” and further argues that advances in quantum control can refine clarity and reduce scan time, linking imaging performance to relaxation mechanisms and and to signal-to-noise improvements that can reduce scan time while improving resolution[9]. The same body of reviews describes PET as a frontier for quantum optics, reporting experimental efforts that use entangled photon pairs and photon-number-resolving detectors to achieve sub-millimeter resolution in PET imaging[9].
Quantum imaging more broadly is described as leveraging entanglement and photon correlations to obtain higher resolution, contrast, and signal-to-noise ratio than classical optics, and as extending imaging beyond anatomical structures to metabolic processes and molecular interactions in real time[8]. This framing is directly linked to clinical aspirations, such as minimizing exposure while maintaining accuracy and enabling visualization of soft tissues or biomolecules that are transparent to visible light, including via quantum super-resolution approaches that use multi-photon interference and entangled light states[8].
Quantum sensing
Quantum sensors are positioned as a pathway to enhanced biomedical measurement because they can deliver greater sensitivity and higher spatial resolution by “applying quantum properties for enhanced performance,” which is then mapped onto medical goals such as more precise localization of magnetic signals from the brain and heart[10]. Wearability and clinical practicality are repeatedly emphasized, including proposals for lightweight helmets or belts with arrays of small sensors (e.g., based on neutral atoms or diamond defects) and the claim that further development could enable operation under ambient conditions without cryogenics or shielded rooms[10]. A near-term to long-term translation narrative is also explicit, with one review projecting near-term applications in research bioimaging, spectroscopy, and microscopy for molecular analysis, and longer-term applications in medical imaging/diagnosis and analysis of drug effectiveness[10].
NV-center sensing is repeatedly highlighted as an exemplar of clinically relevant quantum sensing because NV centers can maintain coherence at room temperature and can be used as quantum biosensors for weak magnetic fields, which the literature links to neuronal magnetic signals and even biomolecular-scale detection[8]. This same framing is connected to oncology and neuroscience use-cases, including the claim that NV magnetometers have been used to map brain-like magnetic activity in laboratory models and that NV centers can identify abnormal metabolic patterns or magnetic anomalies attributed to tumor cells, which is framed as enabling earlier malignancy detection than current imaging permits[8].
Quantum computing and quantum machine learning
Across multiple surveys and narrative reviews, quantum computing is framed as relevant to medicine because it may address computational challenges described as “insurmountable for classical computers,” especially in drug discovery, genomics, personalized medicine, and radiotherapy optimization tasks such as Monte Carlo dose calculation and treatment-plan optimization[6]. Several authors explicitly ground this in qubit-level properties, noting that qubits can leverage superposition and entanglement and thus represent exponentially more information than classical bits in certain formulations, which is used to motivate potential advantages in molecular simulation and pattern recognition for biomedical data[6, 11].
Proof-of-concept clinical and medical quantum computing applications are reported across “genomics, clinical research and discovery, diagnostics, and treatments and interventions,” and one review argues that quantum machine learning has rapidly evolved and can be competitive with classical benchmarks on downsized versions of medical problems[12]. The same review connects this trajectory to a longer-term vision of proactive, individualized guidance, while also emphasizing practical prerequisites for clinical uptake such as data accessibility, explainability to obtain clinician support, and patient privacy[12].
Within imaging-focused QML reviews, the motivation is frequently framed as clinical pressure for faster and more accurate diagnoses amid rising scan volumes and clinician shortages, and hybrid quantum–classical models are presented as a response to demands for better signal processing in MRI and EEG[13]. These papers report concrete examples including a QML classifier for Alzheimer’s disease severity grading implemented on 5-qubit hardware or simulators, quantum-enhanced EEG models (QEEGNet) outperforming traditional EEGNet on a competition dataset, and quantum CT reconstruction algorithms aimed at mitigating artifacts of classical reconstruction methods[13].
QML surveys also emphasize that most medical QML studies are still performed on simulators rather than real quantum hardware, with this limitation attributed to the early development stage of quantum hardware and limited accessibility of quantum processors, even as medical workloads are described as motivating automation support for disease classification[14]. Complementary QML literature highlights both promise and constraints, noting that quantum SVMs, QCNNs, and variational quantum circuits are explored for high-dimensional medical imaging tasks, while also pointing to barren plateaus and NISQ noise, limited qubit counts, and high error rates as practical barriers on actual devices[15].
Quantum dots and photonic devices
Quantum dots are repeatedly described as nanoscale semiconductor particles whose quantum confinement leads to optical emission at specific wavelengths with high brightness and stability, and this property is used to justify their value in optical imaging and diagnostics[9]. Dedicated QD reviews emphasize tunable fluorescence, high quantum yield, and membrane penetration as enabling capabilities for high-resolution cellular and biomolecular imaging and for targeted drug delivery, while also warning that long-term stability, toxicity, environmental impact, and bioaccumulation are key translational risks that must be mitigated through improved biocompatibility and surface modification[16].
In point-of-care diagnostics, QDs are positioned as fluorescent reporters because of “large absorption coefficients, tunable emission spectra, and enhanced photostability,” and are described as improving rapid diagnostic performance in microfluidics and lateral flow immunoassays by lowering detection limits and enabling multiplexing through size-tunable emission wavelengths[17]. These POC applications are linked to clinical operations by examples such as antibody-conjugated QDs for selective fluorescence readouts, sub-ng/mL viral antigen detection in some test strips, and short turnaround times (often under half an hour) that can alleviate laboratory burdens and speed clinical decisions[17].
Beyond QDs, photonic quantum devices such as quantum cascade lasers are proposed for nonthermal theranostic scans, with claimed suitability for biological tissues due to mid-IR and terahertz coverage, penetration, and absorption spectra, alongside claims that selective action on pathological tissues could support minimally invasive diagnosis and treatment[18].
Quantum cryptography and medical data security
Several reviews make the case that quantum cryptography is clinically relevant because healthcare depends on confidentiality and integrity of patient data, including electronic health records and telemedicine communications[7, 19]. Quantum key distribution is presented as enabling exchange of encryption keys with “absolute security” and as being able to detect eavesdropping because measurement disturbs quantum systems and introduces detectable anomalies in intercepted transmissions[7, 19]. Adoption pressures are described explicitly, with one narrative review stating that hospitals and medical facilities are increasingly adopting quantum cryptography to protect EHRs and describing quantum-secured telecommunications as confidential and tamper-proof for remote consultations and exchange of vital patient information[19].
The table below summarizes key applied intersections and the types of clinical value they are primarily framed to deliver in the reviewed sources.
Quantum biology and health
Quantum biology is presented as an emerging field that investigates whether quantum phenomena (including superposition, entanglement, tunneling, and coherence) can influence biological processes at molecular and cellular scales, particularly where classical mechanics may be insufficient for atomic/subatomic interactions[20]. The literature argues for specific mechanistic candidates: quantum coherence is proposed as supporting efficient energy transfer in photosynthesis, and quantum tunneling is implicated in proton transfer during enzyme catalysis, with the further claim that understanding such quantum principles could inform design of more effective drugs[20].
A more explicitly translational framing appears in “quantum biomedicine” reviews that argue biological systems are “quantum systems” in a literal sense and that multiple life-essential processes (electron tunnelling in respiratory complexes, proton-coupled transfer in metabolic enzymes, coherence in photosynthesis, and spin dynamics in radical signalling) are inherently quantum mechanical, thereby proposing a mechanistic layer connecting electronic-scale physics to clinical phenotypes[2]. These reviews also explicitly connect the quantum-biology agenda to quantum technologies by highlighting quantum-native algorithms (VQE, QPE, QITE) aimed at strongly correlated electronic problems beyond classical reach and by noting that current implementations are constrained by NISQ-era hardware even as algorithms and sensing advances are framed as emerging tools for precision and translational medicine[2].
A key synthesis device in this subliterature is the proposed Quantum–Experimental–Clinical (QEC) pipeline, described as integrating quantum simulations with experimental validation and multi-omics clinical data to interpret disease phenotypes and identify redox- and spin-sensitive therapeutic targets, including applications discussed for cancer metabolism, neurodegenerative protein misfolding, immune/inflammatory signaling, infectious disease mechanisms, and drug discovery[2]. The same framework explicitly situates quantum sensors (especially NV-center-based) as tools for detecting minute changes in magnetic fields, electric fields, temperature, and redox states that are described as central to disease biology, and it argues that iterative workflows can accelerate translation from molecular simulations to precision medicine[2].
A broader perspective review emphasizes that quantum effects were historically viewed as unlikely in living systems due to expected decoherence in warm, wet, noisy environments, but argues that evidence across diverse biological functions has led to the emergence of quantum biology and has raised clinician-relevant questions about how quantum-classical cutoffs might affect insights into health and disease, including cancer management aspirations[4].
Theoretical and philosophical common aspects
Some literature at the quantum–medicine boundary focuses less on devices or biochemical mechanisms and more on theoretical claims about mind and observation. One review argues that quantum mechanics is more suited than classical mechanics to “accommodate consciousness,” and explicitly claims that quantum-state reductions and wave function collapse could physically represent how conscious decisions become definite outcomes as neurological networks transmit information[3]. The same review ties this to the quantum measurement problem by framing consciousness and reality as connected through the question of why we do not consciously perceive quantum superpositions but instead perceive definite states or locations, and it presents this as a conceptual bridge between quantum theory and conscious perception[3].
Within the same line of argumentation, authors propose potential medical implications by suggesting that quantum-inspired descriptions of neuronal assembly and collapse to a “singular final state” could help describe changes in neural activity during neurodegenerative disease (e.g., Alzheimer’s disease) and that anesthetic inhibition of conscious activity could be mapped using quantum projections and eigenstate language[3]. These proposals are presented as potentially consequential for medicine in that review, which states that the posited theory “could have enormous implications for the field of medicine”[3].
Synthesis
Across the reviewed literature, common threads emerge that tie quantum physics and medicine together through shared mechanisms, constraints, and translational goals.
- First, many authors treat quantum phenomena as enabling resources for both computation and measurement, repeatedly emphasizing superposition and entanglement as the conceptual basis for quantum computing, quantum sensing, and quantum cryptography, and then mapping these to drug discovery, diagnostics, and secure health data exchange[1, 19].
- Second, the field is unified by a “scale-bridging” aspiration in which electronic- and spin-scale processes are linked to clinically observable phenotypes, as explicitly stated in quantum biomedicine work that describes a mechanistic layer connecting electronic-scale processes to clinical phenotypes and proposes integrated QEC translation pipelines to connect simulations, experiments, and multi-omics clinical data[2].
- Third, the literature frames measurement, sensitivity, and coherence as shared operational constraints, with coherence time explicitly linked to diagnostic sensitivity in quantum biosensing and with room-temperature coherence in NV centers treated as a practical route to clinically relevant magnetometry, while quantum imaging is framed as enabling high-resolution, low-exposure imaging through entanglement and photon correlations[8].
- Fourth, a recurring computational commonality is that many of the healthcare tasks targeted (molecular simulation, docking, genomics analytics, dose planning) are high-dimensional and optimization-heavy, and authors repeatedly argue that quantum computing’s value lies in accelerating or improving simulation and optimization for these tasks, including radiotherapy optimization and Monte Carlo dose calculation[6, 21].
- Fifth, the boundary between quantum and classical behavior is itself treated as a medically relevant research question, because biological environments are argued to challenge coherent quantum effects through decoherence while other reviews argue that quantum explanations better fit certain biological phenomena and could open new approaches to diagnosis and disease management if core processes meaningfully use quantum mechanics[4].
Limitations and outlook
Across the applied literature, a consistent limitation is that quantum computing hardware remains largely experimental and is “presently unable” to solve relevant healthcare questions competitively with traditional high-performance computing, even as attention and investment increase and proof-of-concept demonstrations expand[11]. NISQ-era constraints are also repeatedly foregrounded, including device noise, decoherence, error rates, limited qubits, and scalability issues, as well as algorithmic barriers such as variational optimization difficulties (including barren plateaus), which collectively limit immediate deployment for robust clinical workloads[15, 22].
For QML specifically, surveys report that many medical QML experiments still rely on simulators rather than real hardware due to limited access and early hardware maturity, which implies that performance comparisons and generalization to clinical-scale problems remain active research challenges[14]. In parallel, clinically oriented QC reviews stress that translation will require non-technical conditions such as data accessibility, explainability, and privacy to build clinician trust, and some drug-discovery pipeline reviews add that clinical trial data complexity and stringent privacy requirements create bottlenecks that motivate secure data integration frameworks[12, 23].
In quantum sensing and imaging, the outlook presented is optimistic but developmental, with envisioned progress toward wearable, ambient-condition biosensors and toward quantum imaging methods that can minimize exposure while improving resolution and enabling molecular-scale or metabolic imaging, implying a staged roadmap from research bioimaging and spectroscopy into clinical imaging and diagnosis[8, 10]. In quantum dot translation, the literature consistently pairs imaging and point-of-care potential with toxicity and bioaccumulation concerns, and it describes surface ligand exchange and encapsulation strategies as active approaches for improving biocompatibility and safety, suggesting that materials engineering and regulatory evaluation are likely to be determining factors for clinical uptake[16].
